Association between Urinary Phthalate Metabolites and Markers of Endothelial Dysfunction in Adolescents and Young Adults
Journal
Toxics
Journal Volume
9
Journal Issue
2
Date Issued
2021-02-06
Author(s)
Abstract
Endothelial function is crucial in the pathogenesis of circulatory and cardiovascular toxicity; epidemiologic research investigating the association between phthalate exposure and endothelial dysfunction remains limited. We examined the associations between exposures to specific phthalates (di-2-ethylhexyl phthalate, DEHP; di-n-butyl phthalate, DnBP) and circulating endothelial and platelet microparticles (EMPs and PMPs) in adolescents and young adults. Of the 697 participants recruited, anthropometric measurements and health-related behaviors relevant to cardiovascular risks were collected and assessed. Urine and serum were collected and analyzed with liquid chromatography-tandem mass spectrometry (LC-MS/MS) and flow cytometry. Multiple linear regression indicated that increases in urinary concentrations of ΣDEHP and MnBP (mono-n-butyl phthalate), across quartiles, were positively associated with serum EMPs level (p for trend <0.001 and <0.001; β = 0.798 and 0.007; standard error = 0.189 and 0.001, respectively). Moreover, female and overweight subjects had higher MnBP, and males were more vulnerable to DnBP exposure compared to females. In conclusion, our results demonstrate a dose-response relationship between exposures to phthalates (ΣDEHP and MnBP) and microparticle formation (EMPs and PMPs) in adolescents and young adults. The findings indicate that exposures to phthalates of both low and high-molecular weight are positively associated with microparticle production, and might contribute to endothelial dysfunction; such damage might manifest in the form of atherosclerotic-related vascular diseases. Future in vivo and in vitro studies are warranted to elucidate whether a causal relationship exists between phthalate exposure and EMPs and PMPs.
Subjects
cardiotoxicity; di-n-butyl phthalate; endothelial dysfunction; microparticles; phthalates
SDGs
Other Subjects
antihypertensive agent; insulin; mono n butyl phthalate; oral antidiabetic agent; phthalic acid bis(2 ethylhexyl) ester; phthalic acid derivative; phthalic acid dibutyl ester; unclassified drug; adolescent; adult; antihypertensive therapy; Article; blood level; blood sampling; cardiotoxicity; cardiovascular risk; cohort analysis; cross-sectional study; data analysis software; diabetes mellitus; endothelial dysfunction; endothelial microparticle; environmental exposure; female; flow cytometry; health behavior; human; hypertension; insulin treatment; liquid chromatography-mass spectrometry; major clinical study; male; obesity; platelet microparticle; sex difference; urine level; urine sampling; young adult
Type
journal article